InMed Pharmaceuticals, Inc. (INM)

1.36 +0.03 (+2.26%) USD  |  NASDAQ  |  Oct 09, 16:00
1.37 +0.01 (+0.74%) After-Hours: 20:00
More

InMed Pharmaceuticals Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for INM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Current Quarter Data

View and export this data back to 2022. Start Trial.
Date Value
February 16, 2024 --
January 17, 2024 --
December 31, 2023 --
November 16, 2023 --
October 02, 2023 --
Date Value
September 30, 2023 --
July 20, 2023 --
June 30, 2023 --
May 13, 2022 --

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
NervGen Pharma Corp. Upgrade
Milestone Pharmaceuticals, Inc. Upgrade
Clearmind Medicine, Inc. --
Lexaria Bioscience Corp. Upgrade
Target Group, Inc. (Canada) --

Revenue Estimates for Current Quarter Related Metrics

Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade